“Prescription drug prices are out of control,” wrote AHA President and CEO Rick Pollack and America’s Health Insurance Plans President and CEO Marilyn Tavenner in a Dec. 31 OpEd in The Hill. “The average annual cost for one specialty medication to treat a chronic condition is now more than what most families earn in a year. Big Pharma could solve the problem by committing to more rational and sustainable pricing models. Instead, for the last year, Big Pharma has chosen to point the finger at everyone else, and their decision to engage in a blame game is a tacit admission that drug prices are, in fact, too high.” To read the full column, click here.

Related News Articles

Headline
The Centers for Disease Control and Prevention May 29 published a blog co-authored by AHA, the National Institute for Occupational Safety and Health and the…
Headline
A report released May 29 by the Government Accountability Office found a lack of state oversight on Medicaid managed care plans’ use of prior authorization for…
Headline
The AHA commented May 28 on the Centers for Medicare & Medicaid Services’ proposed rule for the inpatient psychiatric facility prospective payment system…
Headline
The Senate Committee on Health, Education, Labor and Pensions May 23 passed legislation that included proposals on mental health and emergency pediatric…
Headline
Behavioral health conditions among older populations are often underrecognized, undertreated and stigmatized, according to the World Health Organization. Learn…
Headline
The Centers for Medicare & Medicaid Services recently announced the approval of Delaware and Tennessee as the first states to provide diapers to children…